UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1

EBioMedicine, 2020-09, Vol.59, p.102955-102955, Article 102955

2020

Volltextzugriff (PDF)

Impact of Secondary Aneurysmal Bone Cysts on Survival of Patients with Enneking Stage IIB Extremity Osteosarcoma: A Propensity Score Matching Analysis

Annals of surgical oncology, 2021-11, Vol.28 (12), p.7864-7872

2021

Volltextzugriff (PDF)

TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1

Journal of experimental & clinical cancer research, 2020-01, Vol.39 (1), p.23-17, Article 23

2020

Volltextzugriff (PDF)

Correction: TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1

Journal of experimental & clinical cancer research, 2022-07, Vol.41 (1), p.1-221, Article 221

2022

Volltextzugriff (PDF)

Safety and efficacy of fruquintinib‐based therapy in patients with advanced or metastatic sarcoma

Cancer medicine (Malden, MA), 2024-07, Vol.13 (13), p.e7438-n/a

2024

Volltextzugriff (PDF)

A pilot study of multi-antigen stimulated cell therapy-I plus camrelizumab and apatinib in patients with advanced bone and soft-tissue sarcomas

BMC medicine, 2023-11, Vol.21 (1), p.470-470, Article 470

2023

Volltextzugriff (PDF)

Surgical Management of Cardiac Masses in Right Atrium Among Bone Sarcoma Pediatric Patients With Totally Implanted Ports

Frontiers in oncology, 2022-06, Vol.12, p.926387-926387

2022

Volltextzugriff (PDF)

Case Report: Sequential Chemotherapy and Immunotherapy Produce Sustained Response in Osteosarcoma With High Tumor Mutational Burden

Frontiers in endocrinology (Lausanne), 2021-06, Vol.12, p.625226

2021

Volltextzugriff (PDF)

18F-FDG positron emission tomography for the assessment of histological response to neoadjuvant chemotherapy in osteosarcomas: A meta-analysis

Surgical oncology, 2012-12, Vol.21 (4), p.e165-e170

2012

Volltextzugriff (PDF)

Oncometabolite D-2-hydroxyglutarate—dependent metabolic reprogramming induces skeletal muscle atrophy during cancer cachexia

Communications biology, 2023-09, Vol.6 (1), p.977-977, Article 977

2023

Volltextzugriff (PDF)

Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis

European journal of cancer (1990), 2014-04, Vol.50 (6), p.1125-1136

2014

Volltextzugriff (PDF)

The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data

PloS one, 2013-06, Vol.8 (6), p.e64513-e64513

2013

Volltextzugriff (PDF)

D2HGDH-mediated D2HG catabolism enhances the anti-tumor activities of CAR-T cells in an immunosuppressive microenvironment

Molecular therapy, 2022-03, Vol.30 (3), p.1188-1200

2022

Volltextzugriff (PDF)

Mutational landscape of Chinese osteosarcoma patients

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e23512-e23512

2021

Volltextzugriff (PDF)

Clinical significance of indeterminate pulmonary nodules on the survival of 364 patients with nonmetastatic, high‐grade, localized osteosarcoma: A 12‐year retrospective cohort study

Journal of surgical oncology, 2021-02, Vol.123 (2), p.587-595

2021

Volltextzugriff (PDF)

FAT1 and MSH2 Are Predictive Prognostic Markers for Chinese Osteosarcoma Patients Following Chemotherapeutic Treatment

Journal of bone and mineral research, 2022-05, Vol.37 (5), p.885-895

2022

Volltextzugriff (PDF)

SKA1 induces de novo MTX‐resistance in osteosarcoma through inhibiting FPGS transcription

The FEBS journal, 2019-06, Vol.286 (12), p.2399-2414

2019

Volltextzugriff (PDF)

SKA 1 induces de novo MTX ‐resistance in osteosarcoma through inhibiting FPGS transcription

The FEBS journal, 2019-06, Vol.286 (12), p.2399-2414

2019

Volltextzugriff (PDF)

First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti-PD-L1 Antibody ZKAB001

Clinical cancer research, 2023-02, Vol.29 (4), p.764-774

2023

Volltextzugriff (PDF)

Heterogeneous expression and biological function of ubiquitin carboxy-terminal hydrolase-L1 in osteosarcoma

Cancer letters, 2015-04, Vol.359 (1), p.36-46

2015

Volltextzugriff (PDF)

Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy

Asia-Pacific journal of clinical oncology, 2013-03, Vol.9 (1), p.71-79

2013

Volltextzugriff (PDF)

Pirarubicin-based chemotherapy displayed better clinical outcomes and lower toxicity than did doxorubicin-based chemotherapy in the treatment of non-metastatic extremity osteosarcoma

American journal of cancer research, 2015-01, Vol.5 (1), p.411-422

2015

Volltextzugriff (PDF)

Effects of STI571 on the Development of Dendritic Cells Derived from Bone Marrow Mononuclear Cells from Patients with Chronic Myeloid Leukemia

Blood, 2005-11, Vol.106 (11), p.4874-4874

2005

Volltextzugriff (PDF)

Clinical analysis of Chinese limb osteosarcoma patients treated by two combinations of methotrexate, cisplatin, doxorubicin and ifosfamide

Asia-Pacific journal of clinical oncology, 2011-09, Vol.7 (3), p.270-275

2011

Volltextzugriff (PDF)

Analysis of prognostic factors in 333 C hinese patients with high‐grade osteosarcoma treated by multidisciplinary combined therapy

Asia-Pacific journal of clinical oncology, 2013-03, Vol.9 (1), p.71-79

2013

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(34)
Berichte
(1)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

Science & Technology
(23)
Life Sciences & Biomedicine
(22)
Humans
(17)
Oncology
(17)
Osteosarcoma
(12)
Chemotherapy
(8)
Female
(8)
Male
(8)
Adolescent
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Bone Cancer
(7)
Bone Neoplasms - Drug Therapy
(7)
Bone Neoplasms - Pathology
(7)
Sarcoma
(7)
Adult
(6)
Cell Line, Tumor
(6)
Osteosarcoma - Drug Therapy
(6)
Osteosarcoma - Pathology
(6)
Prognosis
(6)
Animals
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1

Impact of Secondary Aneurysmal Bone Cysts on Survival of Patients with Enneking Stage IIB Extremity Osteosarcoma: A Propensity Score Matching Analysis

TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1

Correction: TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1

Safety and efficacy of fruquintinib‐based therapy in patients with advanced or metastatic sarcoma

A pilot study of multi-antigen stimulated cell therapy-I plus camrelizumab and apatinib in patients with advanced bone and soft-tissue sarcomas

Surgical Management of Cardiac Masses in Right Atrium Among Bone Sarcoma Pediatric Patients With Totally Implanted Ports

Case Report: Sequential Chemotherapy and Immunotherapy Produce Sustained Response in Osteosarcoma With High Tumor Mutational Burden

18F-FDG positron emission tomography for the assessment of histological response to neoadjuvant chemotherapy in osteosarcomas: A meta-analysis

Oncometabolite D-2-hydroxyglutarate—dependent metabolic reprogramming induces skeletal muscle atrophy during cancer cachexia

Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis

The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data

D2HGDH-mediated D2HG catabolism enhances the anti-tumor activities of CAR-T cells in an immunosuppressive microenvironment

Mutational landscape of Chinese osteosarcoma patients

Clinical significance of indeterminate pulmonary nodules on the survival of 364 patients with nonmetastatic, high‐grade, localized osteosarcoma: A 12‐year retrospective cohort study

FAT1 and MSH2 Are Predictive Prognostic Markers for Chinese Osteosarcoma Patients Following Chemotherapeutic Treatment

SKA1 induces de novo MTX‐resistance in osteosarcoma through inhibiting FPGS transcription

SKA 1 induces de novo MTX ‐resistance in osteosarcoma through inhibiting FPGS transcription

First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti-PD-L1 Antibody ZKAB001

Heterogeneous expression and biological function of ubiquitin carboxy-terminal hydrolase-L1 in osteosarcoma

Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy

Pirarubicin-based chemotherapy displayed better clinical outcomes and lower toxicity than did doxorubicin-based chemotherapy in the treatment of non-metastatic extremity osteosarcoma

Effects of STI571 on the Development of Dendritic Cells Derived from Bone Marrow Mononuclear Cells from Patients with Chronic Myeloid Leukemia

Clinical analysis of Chinese limb osteosarcoma patients treated by two combinations of methotrexate, cisplatin, doxorubicin and ifosfamide

Analysis of prognostic factors in 333 C hinese patients with high‐grade osteosarcoma treated by multidisciplinary combined therapy

Suchergebnisse filtern